NEW YORK, Aug. 3 /PRNewswire/ -- On August 2, Marvin Loeb, Chairman and CEO of Trimedyne, Inc. (OTC:TMED) (BULLETIN BOARD: TMED) updated the investment community in an exclusive interview with...
Lumenis and Trimedyne Settle Litigation YOKNEAM, Israel, Dec. 16 /PRNewswire-FirstCall/ -- Lumenis Ltd. and Trimedyne, Inc. (BULLETIN BOARD: TMED) today announced they have agreed to...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.245 | 445.454545455 | 0.055 | 0.38 | 0.04 | 1036 | 0.04051564 | CS |
4 | 0.215 | 252.941176471 | 0.085 | 0.38 | 0.04 | 976 | 0.05707395 | CS |
12 | 0.215 | 252.941176471 | 0.085 | 0.38 | 0.04 | 374 | 0.05984942 | CS |
26 | 0.105 | 53.8461538462 | 0.195 | 0.38 | 0.04 | 2270 | 0.12693134 | CS |
52 | 0.025 | 9.09090909091 | 0.275 | 0.395 | 0.04 | 1906 | 0.16532161 | CS |
156 | 0.25 | 500 | 0.05 | 2.37 | 0.01 | 16891 | 0.29627012 | CS |
260 | -0.69 | -69.696969697 | 0.99 | 3.95 | 0.01 | 46806 | 0.28260093 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales